Cargando…
Patient‐derived organoids as a preclinical platform for precision medicine in colorectal cancer
Patient‐derived organoids are being considered as models that can help guide personalized therapy through in vitro anticancer drug response evaluation. However, attempts to quantify in vitro drug responses in organoids and compare them with responses in matched patients remain inadequate. In this st...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208081/ https://www.ncbi.nlm.nih.gov/pubmed/34850547 http://dx.doi.org/10.1002/1878-0261.13144 |